AUTHOR
Mick Weinstein
380 postsYou may also like
Markets were blindsided from recent political events in the UK and China
New York Times: Celgene (CELG) shareholders on InvestorVillage are frustrated with how much Celgene executives make while their returns on the stock lag.
The US and China continue to clash over trade
With the offering now seemingly set for May, here’s a fresh look at past IPO performance, new thoughts on valuation and potential scams and fees to avoid.